ANGEN.E — Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret A Cashflow Statement
0.000.00%
- TRY2.44bn
- TRY2.24bn
- TRY529.83m
Annual cashflow statement for Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret A, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Interim Report | ARS | ARS | ARS | ARS |
Standards: | — | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 316 | 443 | -10.1 | -197 | -219 |
Depreciation | |||||
Non-Cash Items | 45.9 | -37.6 | -86.4 | 140 | 137 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -132 | -8.43 | -98.7 | 32.1 | -20.4 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 235 | 407 | -135 | 61.1 | 7.51 |
Capital Expenditures | -69.6 | -77.4 | -141 | -167 | -246 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 2.12 | 10 | -70.7 | 16.1 | 19.7 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -67.5 | -67.4 | -212 | -151 | -227 |
Financing Cash Flow Items | -59.7 | -2.07 | 27.8 | 39.9 | 0.091 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -34.9 | -12.8 | -545 | -236 | -11.3 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 133 | 327 | -893 | -326 | -231 |